Pinkerton Retirement Specialists’s Regeneron Pharmaceuticals REGN Stock Holding History

Pinkerton Retirement Specialists’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,159	Closed	-$723K	–	93
2020 Q2	$723K	Buy	+1,159	New	+$658K	0.23%	65
2017 Q1	–	Sell	-6	Closed	-$2K	–	416
2016 Q4	$2K	Hold	6	–	–	﹤0.01%	520
2016 Q3	$2K	Sell	6 -1	-14%	-$401	﹤0.01%	523
2016 Q2	$2K	Buy	+7	New	+$2.7K	﹤0.01%	524

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pinkerton Retirement Specialists's REGN Position: Q3 2020 in Review

Pinkerton Retirement Specialists sold out of Regeneron Pharmaceuticals (REGN) in Q3 2020, closing a stake of 1,159 shares — an estimated $723K sold.

Pinkerton Retirement Specialists first reported a position in REGN in Q2 2016 and held it in 4 quarters. The position peaked at $723K in Q2 2020. 907 funds tracked by Wall St. Rank hold REGN as of Q3 2020.

Pinkerton Retirement Specialists reported no remaining Regeneron Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Pinkerton Retirement Specialists sold 1,159 Regeneron Pharmaceuticals shares in Q3 2020, an estimated $723K.
Pinkerton Retirement Specialists first reported a position in Regeneron Pharmaceuticals in Q2 2016 and held it in 4 quarters.
Pinkerton Retirement Specialists's Regeneron Pharmaceuticals position peaked at $723K in Q2 2020.
907 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2020.

Based on Pinkerton Retirement Specialists's 13F filing for Q3 2020, filed 6 Nov 2020.